↓ Skip to main content

Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients With Myelodysplastic Syndromes

Overview of attention for article published in Journal of Clinical Oncology, March 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
patent
5 patents

Citations

dimensions_citation
249 Dimensions

Readers on

mendeley
90 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients With Myelodysplastic Syndromes
Published in
Journal of Clinical Oncology, March 2009
DOI 10.1200/jco.2008.17.1058
Pubmed ID
Authors

Roger M. Lyons, Thomas M. Cosgriff, Sanjiv S. Modi, Robert H. Gersh, John D. Hainsworth, Allen L. Cohn, Heidi J. McIntyre, Indra J. Fernando, Jay T. Backstrom, C.L. Beach

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 2 2%
United Kingdom 2 2%
Malaysia 1 1%
Italy 1 1%
Spain 1 1%
United States 1 1%
Unknown 82 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 24%
Other 14 16%
Professor > Associate Professor 10 11%
Student > Postgraduate 7 8%
Student > Doctoral Student 6 7%
Other 20 22%
Unknown 11 12%
Readers by discipline Count As %
Medicine and Dentistry 65 72%
Pharmacology, Toxicology and Pharmaceutical Science 7 8%
Psychology 2 2%
Computer Science 1 1%
Physics and Astronomy 1 1%
Other 1 1%
Unknown 13 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2022.
All research outputs
#5,446,994
of 25,374,647 outputs
Outputs from Journal of Clinical Oncology
#10,619
of 22,046 outputs
Outputs of similar age
#21,057
of 108,261 outputs
Outputs of similar age from Journal of Clinical Oncology
#73
of 170 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,046 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,261 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 170 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.